6 results found. Viewing page 1 of 2.
Go to page
When it comes to asbestos cancer risks, should workers be treated differently than the general population? That is the question posed in a recent blog opinion published by the Environmental Defense Fund. Unfortunately, the EPA ’s recently ...
Continue Reading...
As Europe aims to reach climate neutrality by 2050, it is grappling with the risk of exposing construction workers to asbestos. Although admirable, Europe’s goal to renovate 220 million buildings in order to “slash energy emissions, ...
Continue Reading...
Nanotechnology has revolutionized multiple industries in its broad application across medical, industrial, consumer and technological sectors. However, certain types of nanotechnology, such as carbon nanotubes (CNTs), have been shown to closely ...
Continue Reading...
SELLAS Life Sciences Group (SELLAS) has announced promising results of a Phase 1 clinical trial of the combination of immunotherapy agents Galinpepimut-S (GPS) and nivolumab for patients with WT1 positive malignant pleural mesothelioma. GPS is an ...
Continue Reading...
Researchers in Japan are working to develop an inhalable powder as a new form of treatment for non-small cell lung cancer and mesothelioma. The inhalable powder is a form of gene therapy containing tumor suppression drugs SFD-p16 and SFD-p53 which ...
Continue Reading...
6 results found. Viewing page 1 of 2.
Go to page